ReviewJournal of family medicine and primary care2025
Osteoporosis evidence landscape to inform policy and practice: A comprehensive scoping review.
Review in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteoporosis is a significant public health concern, leading to increased fracture risk. In Saudi Arabia, the prevalence of osteoporosis is rising, necessitating a thorough understanding of its epidemiology, risk factors, and management challenges. Early detection and targeted interventions are essential to mitigate its impact on health and healthcare costs. This scoping review aims to provide comprehensive insights into the current status of osteoporosis in Saudi Arabia. Methods: A comperehensive search was performed in PubMed, Web of Science, and Scopus for articles on "Osteoporosis" and "Saudi Arabia" published up to April 2025. Eligible studies were original research on prevalence, risk factors, diagnosis, treatment, economic burden, and complications of osteoporosis in Saudi Arabia. Data were synthesized to summarize key insights and identify knowledge gaps. Results: The included studies were 36, the prevalence of osteoporosis ranges from 9.3% to 21.4% among men, while it was estimated to be 26% among postmenopausal women. Key risk factors included advanced age, low (Body Mass Index) BMI, high parity, certain chronic diseases, and the use of specific medications. Diagnostic tools are effective in identifying at-risk individuals. Available treatment improved bone density and reduced fracture rates. Conclusion: This review highlights the high prevalence and economic burden of osteoporosis. Gap analysis emphasizes the need for sex-specific risk assessments, addressing socioeconomic disparities, and improving public health education. Effective prevention and management strategies, including vitamin D supplementation, adequate calcium intake, early monitoring, and screening, are crucial. Adherence to national guidelines can reduce osteoporotic fracture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.